Schedule 13G ownership disclosure
Forma Therapeutics Holdings, Inc.,
Security class unavailable · CUSIP: 34633R104
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,991,705
- Percent of class
- 6.6900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-010174
- Form type
- SC 13G
- Filer
- Forma Therapeutics Holdings, Inc.
- CIK
- CIK 1538927
- Filed
- Feb 01, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership